Last reviewed · How we verify
Rinderon® - DP = betamethasone dipropionate
Rinderon® - DP = betamethasone dipropionate is a Corticosteroid Small molecule drug developed by LEO Pharma. It is currently in Phase 3 development for Severe skin conditions such as psoriasis, eczema, and dermatitis.
Rinderon inhibits the body's inflammatory response by suppressing the production of various pro-inflammatory cytokines.
Rinderon inhibits the body's inflammatory response by suppressing the production of various pro-inflammatory cytokines. Used for Severe skin conditions such as psoriasis, eczema, and dermatitis.
At a glance
| Generic name | Rinderon® - DP = betamethasone dipropionate |
|---|---|
| Sponsor | LEO Pharma |
| Drug class | Corticosteroid |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
Betamethasone dipropionate, the active ingredient in Rinderon, is a synthetic corticosteroid that exerts its anti-inflammatory effects by inhibiting the transcription of inflammatory genes. This results in a decrease in the production of pro-inflammatory cytokines, such as IL-1, IL-6, and TNF-alpha, which are involved in the inflammatory response. By reducing inflammation, Rinderon helps to alleviate symptoms associated with various skin conditions.
Approved indications
- Severe skin conditions such as psoriasis, eczema, and dermatitis
Common side effects
- Skin atrophy
- Hypopigmentation
- Irritation
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Rinderon® - DP = betamethasone dipropionate CI brief — competitive landscape report
- Rinderon® - DP = betamethasone dipropionate updates RSS · CI watch RSS
- LEO Pharma portfolio CI
Frequently asked questions about Rinderon® - DP = betamethasone dipropionate
What is Rinderon® - DP = betamethasone dipropionate?
How does Rinderon® - DP = betamethasone dipropionate work?
What is Rinderon® - DP = betamethasone dipropionate used for?
Who makes Rinderon® - DP = betamethasone dipropionate?
What drug class is Rinderon® - DP = betamethasone dipropionate in?
What development phase is Rinderon® - DP = betamethasone dipropionate in?
What are the side effects of Rinderon® - DP = betamethasone dipropionate?
Related
- Drug class: All Corticosteroid drugs
- Manufacturer: LEO Pharma — full pipeline
- Therapeutic area: All drugs in Dermatology
- Indication: Drugs for Severe skin conditions such as psoriasis, eczema, and dermatitis
- Compare: Rinderon® - DP = betamethasone dipropionate vs similar drugs
- Pricing: Rinderon® - DP = betamethasone dipropionate cost, discount & access